Skip to main content

Docetaxel Injection Shortage

Last Updated: June 24, 2025
Status: Discontinued

To Be Discontinued:

Docetaxel, Injection, 10 mg/1 mL (Pfizer Inc.)

NDC Code: 0409-1732-01
Status: To Be Discontinued
Date of update: January 15, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Oncology
Date discontinued: January 15, 2025
Initial posting date: January 15, 2025
Contact info: 844-646-4398

Docetaxel, Injection, 10 mg/1 mL (Pfizer Inc.)

NDC Code: 0409-7870-01
Status: To Be Discontinued
Date of update: January 15, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Oncology
Date discontinued: January 15, 2025
Initial posting date: January 15, 2025
Contact info: 844-646-4398

Docetaxel, Injection, 160 mg/16 mL (10 mg/mL) Multiple Dose ONCO-TAIN™ Glass Fliptop Vial Novaplus® (Pfizer Inc.)

NDC Code: 0409-0016-01
Status: To Be Discontinued
Date of update: June 24, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Oncology
Date discontinued: June 24, 2025
Initial posting date: June 24, 2025
Contact info: 844-646-4398

Docetaxel, Injection, 20 mg/2 mL (10 mg/mL) Single Dose ONCO-TAIN™ Glass Fliptop Vial Novaplus® (Pfizer Inc.)

NDC Code: 0409-2026-01
Status: To Be Discontinued
Date of update: June 24, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Oncology
Date discontinued: June 24, 2025
Initial posting date: June 24, 2025
Contact info: 844-646-4398

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer